Hong Kong Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Consun Pharmaceutical Group

Market Cap: HK$13.1b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

CSPC Pharmaceutical Group

Market Cap: HK$91.6b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Innovent Biologics

Market Cap: HK$140.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.9b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

Akeso

Market Cap: HK$106.8b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

WuXi Biologics (Cayman)

Market Cap: HK$135.1b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Everest Medicines

Market Cap: HK$17.0b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Keymed Biosciences

Market Cap: HK$15.8b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.

China Shineway Pharmaceutical Group

Market Cap: HK$6.2b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

China Medical System Holdings

Market Cap: HK$32.3b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

China Resources Pharmaceutical Group

Market Cap: HK$28.5b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.9b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

United Laboratories International Holdings

Market Cap: HK$23.9b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Mabpharm

Market Cap: HK$2.2b

A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.

CARsgen Therapeutics Holdings

Market Cap: HK$8.2b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$21.6b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

HBM Holdings

Market Cap: HK$10.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

Qyuns Therapeutics

Market Cap: HK$4.2b

A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.

Ascentage Pharma Group International

Market Cap: HK$20.6b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Transcenta Holding

Market Cap: HK$967.3m

A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.

Ocumension Therapeutics

Market Cap: HK$6.6b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

Xuanzhu Biopharmaceutical

Market Cap: HK$36.5b

Engages in the development, industrialization, and commercialization of small-molecule chemical drugs and macromolecular biopharmaceuticals in China.

Beijing Luzhu Biotechnology

Market Cap: HK$4.6b

A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.

Fusen Pharmaceutical

Market Cap: HK$561.9m

An investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China.

Hua Medicine (Shanghai)

Market Cap: HK$3.0b

Engages in the development and commercialization of drugs for the treatment of diabetes in China.

XtalPi Holdings

Market Cap: HK$39.7b

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$94.4b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Extrawell Pharmaceutical Holdings

Market Cap: HK$242.3m

An investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong.

Genor Biopharma Holdings

Market Cap: HK$1.8b

A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.

Ab&B Bio-Tech JS

Market Cap: HK$16.0b

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.

BioDlink International

Market Cap: HK$1.5b

An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.

Lee's Pharmaceutical Holdings

Market Cap: HK$942.1m

An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: HK$1.2b

Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.

3SBio

Market Cap: HK$63.4b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

Cloudbreak Pharma

Market Cap: HK$5.0b

A clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases.

PuraPharm

Market Cap: HK$195.3m

An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.